Overcoming Challenges in NAFLD/NASH Preclinical Modeling

While the race for the first clinical NASH approval intensifies, preclinical research continues to be limited by multiple factors. There is no ideal preclinical NASH model, naturally recapitulating both the long term metabolic and liver fibrosis components of NASH, and existing clinical tests are not translatable to rodent models.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

Labroots

Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioritize novel targets for drug development and improve the design of genetically reprogrammed cell-based therapies.
Watch Now

High-Throughput and Wide-Range Protein Concentration Determination of Monoclonal Antibodies

Protein concentration is an obligatory critical quality attribute that is necessary to determine total protein content in biopharmaceutical formulations.
Watch Now

Emerging Infectious Diseases and First Responders

At the conclusion of this course, participants will be able to apply the following: Define terms such as biological agent, bioterrorism and bioterrorism attack.
Watch Now

USRM Successfully Launches Stem Cell

U.S. Stem Cell, Inc

Dr. Kristin Comella, Chief Science Officer of U.S. Stem Cell, Inc. a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the successful launch of an open, livestream webinar series designed to inform and educate the public on the benefits and applications of stem cell therapy.
Watch Now

Spotlight

resources